Paper36901938
Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
Datlibagi A and 5 others. Int J Mol Sci, 2023. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy. Papers, record 36901938. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901938
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vitreoretinopathy, Proliferative | Major topic |
| Humans | |
| Mice | |
| Rats | |
| Animals | |
| Rabbits | |
| Swine | |
| Epithelial-Mesenchymal Transition | |
| Endothelial Cells | |
| Retinal Pigment Epithelium | |
| Disease Models, Animal |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CDR J.0128.23 | Fund for Scientific Research | PubMed | ||
| Fonds Erasme pour la recherche médicale | PubMed | |||
| Fund IRIS-Research managed by the King Baudouin Foundation | PubMed |
Source PubMed
References142
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23341014 | Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23341014 | PubMed |
| 2 | 25829415 | A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics. | Invest Ophthalmol Vis Sci | 2015 | https://conductscience.org/library/papers/25829415 | PubMed |
| 3 | 33953964 | The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury. | J Ophthalmol | 2021 | https://conductscience.org/library/papers/33953964 | PubMed |
| 4 | 32334405 | Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. | Transl Oncol | 2020 | https://conductscience.org/library/papers/32334405 | PubMed |
| 5 | 10657752 | Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR). | Ophthalmic Res | 2000 | https://conductscience.org/library/papers/10657752 | PubMed |
| 6 | 18599521 | Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. | Diabetes | 2008 | https://conductscience.org/library/papers/18599521 | PubMed |
| 7 | 25152359 | Plasma membrane protein polarity and trafficking in RPE cells: past, present and future. | Exp Eye Res | 2014 | https://conductscience.org/library/papers/25152359 | PubMed |
| 8 | 34926193 | Upregulation of ASPP2 expression alleviates the development of proliferative vitreoretinopathy in a rat model. | Int J Ophthalmol | 2021 | https://conductscience.org/library/papers/34926193 | PubMed |
| 9 | 18926819 | Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy. | Exp Eye Res | 2008 | https://conductscience.org/library/papers/18926819 | PubMed |
| 10 | 30336127 | Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide. | Exp Eye Res | 2019 | https://conductscience.org/library/papers/30336127 | PubMed |
| 11 | 34283209 | Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition. | Invest Ophthalmol Vis Sci | 2021 | https://conductscience.org/library/papers/34283209 | PubMed |
| 12 | 16419035 | Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies. | J Cell Physiol | 2006 | https://conductscience.org/library/papers/16419035 | PubMed |
| 13 | 15718827 | Effects of retinoic acid on retinal pigment epithelium from excised membranes from proliferative vitreoretinopathy. | J Ocul Pharmacol Ther | 2005 | https://conductscience.org/library/papers/15718827 | PubMed |
| 14 | 29532788 | Inhibitory Effects of Plumbagin on Retinal Pigment Epithelial Cell Epithelial-Mesenchymal Transition In Vitro and In Vivo. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/29532788 | PubMed |
| 15 | 17294388 | Expression of proteins associated with cell-matrix adhesion in proliferative vitreoretinopathy designed by Dispase model. | Eur J Ophthalmol | 2007 | https://conductscience.org/library/papers/17294388 | PubMed |
| 16 | 19324843 | Growth factors outside the PDGF family drive experimental PVR. | Invest Ophthalmol Vis Sci | 2009 | https://conductscience.org/library/papers/19324843 | PubMed |
| 17 | 12883645 | IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy. | Int J Mol Med | 2003 | https://conductscience.org/library/papers/12883645 | PubMed |
| 18 | 12202537 | Effect of 2'-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model. | Invest Ophthalmol Vis Sci | 2002 | https://conductscience.org/library/papers/12202537 | PubMed |
| 19 | 32818015 | Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway. | Mol Vis | 2020 | https://conductscience.org/library/papers/32818015 | PubMed |
| 20 | 12707600 | The role of scleral buckle in experimental posterior penetrating eye injury. | Retina | 2003 | https://conductscience.org/library/papers/12707600 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42211205 | JNK inhibitor SP600125 alleviates TGF-β2-induced epithelial-mesenchymal transition in RPE cell via TGF-βR2/Smad2/3 and JNK/c-Jun pathway. | Int J Ophthalmol | 2026 | https://conductscience.org/library/papers/42211205 | PubMed |
| 41767322 | Vaccinia-related kinase 1/snail family transcriptional repressor 1 regulates epithelial-mesenchymal transition and inflammation in proliferative vitreoretinopathy. | Int J Ophthalmol | 2026 | https://conductscience.org/library/papers/41767322 | PubMed |
| 41529022 | A TGFB2/TNF-induced in vitro model of proliferative vitreoretinopathy (PVR) using ARPE-19 cells confirms nicotinamide as an inhibitor of EMT and VEGFA secretion. | PLoS One | 2026 | https://conductscience.org/library/papers/41529022 | PubMed |
| 41444271 | A novel accessible in vitro model of proliferative vitreoretinal diseases shows facilitated epithelial mesenchymal transition through aquaporin-1. | Sci Rep | 2025 | https://conductscience.org/library/papers/41444271 | PubMed |
| 41147690 | Deficiency of 2-Oxoglutarate Carrier (Slc25a11) Drives RPE Epithelial-to-Mesenchymal Transition and Exacerbates Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration. | Aging Cell | 2025 | https://conductscience.org/library/papers/41147690 | PubMed |
| 41029102 | Pathogenic mechanisms and treatment advances in proliferative vitreoretinopathy: A review. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41029102 | PubMed |
| 40536048 | Establishment of a novel alloxan-induced rabbit model exhibiting unique diabetic retinal neuropathy features assessed via ERG + VEP. | Animal Model Exp Med | 2025 | https://conductscience.org/library/papers/40536048 | PubMed |
| 40508210 | Tacrolimus Modulates TGF-β Signaling-Related Genes and MicroRNAs in Human Retinal Pigment Epithelial Cells Activated by Lipopolysaccharide. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508210 | PubMed |
| 40398745 | JAM-C prevents ocular fibrosis by suppressing the TAZ/KLF6 pathway. | J Adv Res | 2026 | https://conductscience.org/library/papers/40398745 | PubMed |
| 40371355 | Effect of methotrexate/dexamethasone combination on epithelial-mesenchymal transition and inflammation gene expression of human RPE cells in-vitro. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40371355 | PubMed |
| 40140939 | Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy. | J Transl Med | 2025 | https://conductscience.org/library/papers/40140939 | PubMed |
| 40119078 | Involvement of tdTomato-Tagged RPE cells in a mouse PVR model with enzymatically compromised retina. | Sci Rep | 2025 | https://conductscience.org/library/papers/40119078 | PubMed |
| 39612089 | As shown hesperidin suppresses TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells. | J Mol Histol | 2024 | https://conductscience.org/library/papers/39612089 | PubMed |
| 39594586 | Short-Term Culture of Human Hyalocytes Retains Their Initial Phenotype and Displays Their Contraction Abilities. | Cells | 2024 | https://conductscience.org/library/papers/39594586 | PubMed |
| 39213375 | Survivin inhibition attenuates EGF-induced epithelial mesenchymal transformation of human RPE cells via the EGFR/MAPK pathway. | PLoS One | 2024 | https://conductscience.org/library/papers/39213375 | PubMed |
| 38623081 | Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38623081 | PubMed |
| 38153753 | Transition to Chronic Fibrosis in an Animal Model of Retinal Detachment With Features of Proliferative Vitreoretinopathy. | Invest Ophthalmol Vis Sci | 2023 | https://conductscience.org/library/papers/38153753 | PubMed |
| 37906058 | Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation. | Invest Ophthalmol Vis Sci | 2023 | https://conductscience.org/library/papers/37906058 | PubMed |
| 37407754 | Low-dose rosmarinic acid and thymoquinone accelerate wound healing in retinal pigment epithelial cells. | Int Ophthalmol | 2023 | https://conductscience.org/library/papers/37407754 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36901938
GET https://conductscience.org/api/papers/v1/36901938/references?page=2